Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Setting the Stage: Feasibility and Baseline Characteristics in the PARTIQoL Trial Comparing Proton Therapy Versus Intensity Modulated Radiation Therapy for Localized Prostate Cancer.
Wisdom AJ, Yeap BY, Michalski JM, Horick NK, Zietman AL, Christodouleas JP, Kamran SC, Parikh RR, Vapiwala N, Mihalcik S, Miyamoto DT, Zeng J, Gay HA, Pisansky TM, Mishra MV, Spratt DE, Mendenhall NP, Soffen EM, Bekelman JE, Efstathiou JA. Wisdom AJ, et al. Among authors: gay ha. Int J Radiat Oncol Biol Phys. 2024 Sep 30:S0360-3016(24)03444-8. doi: 10.1016/j.ijrobp.2024.09.043. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 39357788
Protecting Caribbean patients diagnosed with cancer from compounding disasters.
Ortiz AP, Hospedales CJ, Méndez-Lázaro PA, Hamilton WM, Rolle LD, Shepherd JM, Espinel Z, Gay HA, Nogueira LM, Shultz JM. Ortiz AP, et al. Among authors: gay ha. Lancet Oncol. 2024 May;25(5):e217-e224. doi: 10.1016/S1470-2045(24)00071-8. Lancet Oncol. 2024. PMID: 38697167 Review.
Beyond Average: α-Particle Distribution and Dose Heterogeneity in Bone Metastatic Prostate Cancer.
Benabdallah N, Lu P, Abou DS, Zhang H, Ulmert D, Hobbs RF, Gay HA, Simons BW, Saeed MA, Rogers BE, Jha AK, Tai YC, Malone CD, Ippolito JE, Michalski J, Jennings JW, Baumann BC, Pachynski RK, Thorek DLJ. Benabdallah N, et al. Among authors: gay ha. J Nucl Med. 2024 Feb 1;65(2):245-251. doi: 10.2967/jnumed.123.266571. J Nucl Med. 2024. PMID: 38124163 Free PMC article.
Does Chemo-Radiotherapy Improve Survival Outcomes vs. Radiotherapy Alone for High-Grade cT1 Urothelial Carcinoma of the Bladder?
Andruska N, Waters MR, Fischer-Valuck BW, Smith ZL, Kim EH, Reimers M, Brenneman R, Gay HA, Patel SA, Michalski JM, Delacroix SE, Efstathiou JA, Baumann BC. Andruska N, et al. Among authors: gay ha. Clin Genitourin Cancer. 2023 Dec;21(6):653-659.e1. doi: 10.1016/j.clgc.2023.07.011. Epub 2023 Aug 2. Clin Genitourin Cancer. 2023. PMID: 37704483 Clinical Trial.
Effect of Brachytherapy With External Beam Radiation Therapy Versus Brachytherapy Alone for Intermediate-Risk Prostate Cancer: NRG Oncology RTOG 0232 Randomized Clinical Trial.
Michalski JM, Winter KA, Prestidge BR, Sanda MG, Amin M, Bice WS, Gay HA, Ibbott GS, Crook JM, Catton CN, Raben A, Bosch W, Beyer DC, Frank SJ, Papagikos MA, Rosenthal SA, Barthold HJ, Roach M 3rd, Moughan J, Sandler HM. Michalski JM, et al. Among authors: gay ha. J Clin Oncol. 2023 Aug 20;41(24):4035-4044. doi: 10.1200/JCO.22.01856. Epub 2023 Jun 14. J Clin Oncol. 2023. PMID: 37315297 Free PMC article. Clinical Trial.
Cellular states are coupled to genomic and viral heterogeneity in HPV-related oropharyngeal carcinoma.
Puram SV, Mints M, Pal A, Qi Z, Reeb A, Gelev K, Barrett TF, Gerndt S, Liu P, Parikh AS, Ramadan S, Law T, Mroz EA, Rocco JW, Adkins D, Thorstad WL, Gay HA, Ding L, Paniello RC, Pipkorn P, Jackson RS, Wang X, Mazul A, Chernock R, Zevallos JP, Silva-Fisher J, Tirosh I. Puram SV, et al. Among authors: gay ha. Nat Genet. 2023 Apr;55(4):640-650. doi: 10.1038/s41588-023-01357-3. Epub 2023 Apr 3. Nat Genet. 2023. PMID: 37012457 Free PMC article.
Logistical, technical, and radiation safety aspects of establishing a radiopharmaceutical therapy program: A case in Lutetium-177 prostate-specific membrane antigen (PSMA) therapy.
Zoberi JE, Garcia-Ramirez J, Luechtefeld D, Maughan NM, Amurao M, Oyama R, Baumann BC, Gay HA, Michalski JM. Zoberi JE, et al. Among authors: gay ha. J Appl Clin Med Phys. 2023 Apr;24(4):e13899. doi: 10.1002/acm2.13899. Epub 2023 Jan 13. J Appl Clin Med Phys. 2023. PMID: 36637862 Free PMC article.
Climate-driven Atlantic hurricanes create complex challenges for cancer care.
Espinel Z, Nogueira LM, Gay HA, Bryant JM, Hamilton W, Trapido EJ, Shepherd JM, Galea S, Shultz JM. Espinel Z, et al. Among authors: gay ha. Lancet Oncol. 2022 Dec;23(12):1497-1498. doi: 10.1016/S1470-2045(22)00635-0. Epub 2022 Oct 18. Lancet Oncol. 2022. PMID: 36272419 No abstract available.
Assessing the impact of brachytherapy boost and androgen deprivation therapy on survival outcomes for patients with unfavorable intermediate-risk prostate cancer patients treated with external beam radiotherapy.
Andruska N, Agabalogun T, Fischer-Valuck BW, Brenneman RJ, Huang Y, Gay HA, Michalski JM, Carmona R, Baumann BC. Andruska N, et al. Among authors: gay ha. Brachytherapy. 2022 Sep-Oct;21(5):617-625. doi: 10.1016/j.brachy.2022.04.001. Epub 2022 May 28. Brachytherapy. 2022. PMID: 35641370 Free PMC article.
94 results